Mass screening for prostate cancer in patients with end-stage renal disease: A comparative study

BJU International

Volumn 98, Issue 4, 2006, Pages 794-797

  Wada, Yoshihiro ^a   Nakanishi, Juro ^a   Takahashi, Wataru ^a   Kai, Nobuyuki ^a   Nakayama, Yoshiharu ^a   Yamashita, Yasuyuki ^a   Honda, Jiro ^a   Ueda, Shoichi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

End stage renal disease; ESRD; Haemodialysis; Mass screening; Prostate cancer; PSA; Renal failure

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER SCREENING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 33748572266     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06374.x     Document Type: Article

References (17)

1. Hernandez J, Thompson IM. Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker. Cancer 2004; 101: 894-904
2. Port FK, Ragheb NE, Schwartz AG, Hawthorne VM. Neoplasms in dialysis patients: a population-based study. Am J Kidney Dis 1989; 14: 119-23
3. Maisonneuve P, Agodoa L, Gellert R et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93-9
4. Nakai S, Shinzato T, Nagura Y et al.; Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo. An overview of regular dialysis treatment in Japan (as of 31 December 2001). Ther Apher Dial 2004; 8: 3-32
5. Mishina T, Watanabe H, Araki H, Nakao M. Epidemiological study of prostatic cancer by matched-pair analysis. Prostate 1985; 6: 423-36
6. Oishi K, Okada K, Yoshida O et al. A case-control study of prostatic cancer with reference to dietary habits. Prostate 1988; 12: 179-90
7. Kuwahara M, Tochigi T, Kawamura S et al. Mass screening for prostate cancer: a comparative study in Natori, Japan and Changchun, China. Urology 2003; 61: 137-41
8. Djavan B, Shariat S, Ghawidel K et al. Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis? Urology 1999; 53: 1169-74
9. Bruun L, Bjork T, Lilja H, Becker C, Gustafsson O, Christensson A. Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment. Nephrol Dial Transplant 2003; 18: 598-602
10. Harper L, McIntyre CW, MacDougall IC, Meyer P, Raine AE, Baker LR. Prostate-specific antigen levels in patients receiving long-term dialysis. Br J Urol 1995; 76: 482-3
11. Sumura M, Yokogi H, Beppu M, Honda H. Diagnostic value of serum prostate-specific antigen in hemodialysis patients. Int J Urol 2003; 10: 247-50
12. Morton JJ, Howe SF, Lowell JA, Stratta RJ, Taylor RJ. Influence of end-stage renal disease and renal transplantation on serum prostate-specific antigen. Br J Urol 1995; 75: 498-501
13. Danisman A, Kilic S, Kukul E et al. Do renal failure and hemodialysis have any effect on the elimination of free and total prostate-specific antigen? Eur Urol 2000; 37: 579-81
14. Tzanakis I, Kazoulis S, Girousis N et al. Prostate-specific antigen in hemodialysis patients and the influence of dialysis in its levels. Nephron 2002; 90: 230-3
15. Hayakawa K, Matsumoto M, Aoyagi T, Miyaji K, Hata M. Prostate cancer with multiple lung metastases in a hemodialysis patient. Int J Urol 2000; 7: 464-6
16. Tsukamoto T, Kumamoto Y, Masumori N et al. Mass screening for prostate carcinoma: a study in Hokkaido, Japan. Eur Urol 1995; 27: 177-81
17. Ito K, Kubota Y, Yamamoto T et al. [The change of mass screening system for prostate cancer in Gunma Prefecture - Present state, and problems for 18 years.] Jpn J Urol Surg 2000; 13: 997-1001